<DOC>
	<DOCNO>NCT02297412</DOCNO>
	<brief_summary>This randomize pilot trial study well minocycline hydrochloride work reduce chemotherapy-induced peripheral neuropathy acute pain patient breast cancer undergo treatment paclitaxel . Drugs use chemotherapy , paclitaxel , may cause damage nerve result ache , pain , tingle numbness finger toe . Minocycline hydrochloride may help lessen nerve damage paclitaxel improve quality life breast cancer patient .</brief_summary>
	<brief_title>Minocycline Hydrochloride Reducing Chemotherapy-Induced Peripheral Neuropathy Acute Pain Patients With Breast Cancer Undergoing Treatment With Paclitaxel</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To estimate whether minocycline hydrochloride ( minocycline ) alleviate paclitaxel-induced peripheral neuropathy . II . To estimate whether minocycline alleviate paclitaxel acute pain syndrome ( P-APS ) . III . To examine possible relative toxicity relate minocycline therapy study situation . OUTLINE : Patients randomize 1 2 arm . ARM I : Patients receive minocycline hydrochloride orally ( PO ) twice daily ( BID ) day 1-7 . Treatment repeat every 7 day 12 course absence disease progression unacceptable toxicity . ARM II : Patients receive placebo PO BID day 1-7 . Treatment repeat every 7 day 12 course absence disease progression unacceptable toxicity . After completion study , patient follow every month 6 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Ability complete questionnaire assistance Planned paclitaxel dose 80 mg/m2 IV give , adjuvant breast cancer ( postoperative neoadjuvant ) setting , every week plan course 12 week without concurrent cytotoxic chemotherapy ( trastuzumab and/or antibody and/or small molecule treatment allow , except PARP inhibitor ) Life expectancy &gt; 6 month Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Negative pregnancy test ( serum urine ) do = &lt; 7 day prior registration , woman childbearing potential ( determine per clinician discretion ) Any follow : Pregnant woman Nursing woman Men woman childbearing potential unwilling employ adequate contraception Previous diagnosis diabetic neuropathy peripheral neuropathy cause History allergic adverse reaction minocycline Prior exposure neurotoxic chemotherapy Diagnosis fibromyalgia Current plan use methoxyflurane , oral contraceptive , isotretinoin , penicillin , ergot alkaloids History allergic adverse reaction tetracycline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>